Myriam Golembo

Myriam Golembo has extensive work experience in the biotechnology and pharmaceutical industry. Myriam currently holds the position of VP Regulatory Affairs at BiomX Inc since January 2020. Prior to that, they served as VP Development at BiomX Inc from July 2017 to January 2020.

Before joining BiomX Inc, Myriam worked as VP Regulatory and Clinical Operations at Efranat Ltd. from May 2016 to June 2017. Myriam was also VP Product Development at Otic Pharma Ltd. from May 2015 to May 2016.

Earlier in their career, Myriam held positions at Protalix Biotherapeutics, starting as an Associate Director of Product Development from May 2009 to May 2012, and later as the Director of Product Development from May 2012 to May 2015.

Myriam also worked as an independent biotechnology consultant and scientific writer from July 2008 to May 2009, and as the Director of Research at Peptera Pharmaceuticals from November 2006 to June 2008.

Myriam's experience also includes working as the Director of Therapeutic Projects Management at Compugen from September 2005 to November 2006, and as the Head of Skeletal Biology and Regeneration at Prochon Biotech Ltd. from an unspecified start date to August 2005.

Myriam began their career as a Research Scientist at the Department of Chemical Pathology, University of Cape Town from April 1990 to June 1993.

Myriam Golembo holds a PhD in Molecular Genetics, which they obtained from the Weizmann Institute of Science between the years 1993 and 1998. Prior to that, they earned their MSc in Molecular Biology from The Hebrew University of Jerusalem, where they studied from 1987 to 1989. In 1984, they completed their BSc in Biology, General, also at The Hebrew University of Jerusalem. Their education journey began in 1983, when they attended Universidad de Montevideo to study Medicine, although it is unclear if they completed a degree in this field.